Geode Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-435,705
| Closed | -$4M | – | 4909 |
|
|
2021
Q2 | $4M | Sell |
435,705
-262,494
| -38% | -$1.53M | ﹤0.01% | 3035 |
|
|
2021
Q1 | $3.47M | Buy |
698,199
+78,219
| +13% | +$378K | ﹤0.01% | 2961 |
|
|
2020
Q4 | $2.67M | Buy |
619,980
+1,727
| +0.3% | +$7.03K | ﹤0.01% | 2920 |
|
|
2020
Q3 | $2.65M | Buy |
618,253
+19,466
| +3% | +$81.3K | ﹤0.01% | 2732 |
|
|
2020
Q2 | $2.69M | Buy |
598,787
+59,481
| +11% | +$266K | ﹤0.01% | 2682 |
|
|
2020
Q1 | $2.16M | Buy |
539,306
+67,259
| +14% | +$571K | ﹤0.01% | 2630 |
|
|
2019
Q4 | $4M | Buy |
472,047
+15,379
| +3% | +$120K | ﹤0.01% | 2593 |
|
|
2019
Q3 | $3.13M | Buy |
456,668
+25,829
| +6% | +$189K | ﹤0.01% | 2667 |
|
|
2019
Q2 | $3.59M | Buy |
430,839
+34,896
| +9% | +$301K | ﹤0.01% | 2600 |
|
|
2019
Q1 | $3.63M | Buy |
395,943
+56,299
| +17% | +$572K | ﹤0.01% | 2509 |
|
|
2018
Q4 | $3.72M | Buy |
339,644
+5,233
| +2% | +$65.9K | ﹤0.01% | 2405 |
|
|
2018
Q3 | $4.67M | Buy |
334,411
+52,685
| +19% | +$713K | ﹤0.01% | 2395 |
|
|
2018
Q2 | $3M | Buy |
281,726
+70,298
| +33% | +$686K | ﹤0.01% | 2613 |
|
|
2018
Q1 | $1.83M | Buy |
211,428
+4,530
| +2% | +$39.7K | ﹤0.01% | 2820 |
|
|
2017
Q4 | $1.96M | Sell |
206,898
-889
| -0.4% | -$6.95K | ﹤0.01% | 2763 |
|
|
2017
Q3 | $1.63M | Buy |
207,787
+69,725
| +51% | +$523K | ﹤0.01% | 2858 |
|
|
2017
Q2 | $1.19M | Buy |
138,062
+69,037
| +100% | +$495K | ﹤0.01% | 3032 |
|
|
2017
Q1 | $486K | Buy |
69,025
+4,081
| +6% | +$25.6K | ﹤0.01% | 3320 |
|
|
2016
Q4 | $276K | Buy |
64,944
+300
| +0.5% | +$1.45K | ﹤0.01% | 3490 |
|
|
2016
Q3 | $321K | Buy |
64,644
+75
| +0.1% | +$317 | ﹤0.01% | 3440 |
|
|
2016
Q2 | $228K | Hold |
64,569
| – | – | ﹤0.01% | 3542 |
|
|
2016
Q1 | $222 | Sell |
64,569
-75
| -0.1% | -$265 | ﹤0.01% | 3598 |
|
|
2015
Q4 | $219K | Buy |
64,644
+150
| +0.2% | +$696 | ﹤0.01% | 3649 |
|
|
2015
Q3 | $335K | Buy |
64,494
+3,865
| +6% | +$23.8K | ﹤0.01% | 3431 |
|
|
2015
Q2 | $413K | Sell |
60,629
-7,252
| -11% | -$51.4K | ﹤0.01% | 3284 |
|
|
2015
Q1 | $484K | Sell |
67,881
-9,912
| -13% | -$68.3K | ﹤0.01% | 3209 |
|
|
2014
Q4 | $579K | Buy |
77,793
+10,362
| +15% | +$87.9K | ﹤0.01% | 3120 |
|
|
2014
Q3 | $623K | Sell |
67,431
-5,149
| -7% | -$69.6K | ﹤0.01% | 3059 |
|
|
2014
Q2 | $1.35M | Buy |
72,580
+25,638
| +55% | +$436K | ﹤0.01% | 2614 |
|
|
2014
Q1 | $869K | Buy |
+46,942
| New | +$895K | ﹤0.01% | 2872 |
|
Other funds holding KIN
Geode Capital Management's KIN Position: Q3 2021 in Review
Geode Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 435,705 shares — an estimated $4M sold.
Geode Capital Management first reported a position in KIN in Q1 2014 and held it in 30 quarters. The position peaked at $4.67M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Geode Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Geode Capital Management sold 435,705 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $4M.
- Geode Capital Management first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 30 quarters.
- Geode Capital Management's Kindred Biosciences, Inc. position peaked at $4.67M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.